(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 7. The final level of SMAD response is sensitive to dpp gene dosage. Confocal projections of embryos stained for Medea (E,F) or PMAD (A-D). 2Xdpp embryos are wild-type (WT) controls, 1Xdpp and 3Xdpp are dppH46/dpp+ and dpp+ P{dppH+}/dpp+, respectively. (A) Stage 7, 3Xdpp embryos show an expanded dorsal region of PMAD staining, which broadens in the trunk region as amnioserosa cells flatten. (B) Stage 7 1Xdpp embryos have weaker PMAD staining. Stage 8 1Xdpp embryos (D,F) have substantially weaker SMAD responses than WT. (D) Stage 8, 1Xdpp embryo with undetectable PMAD staining and partially ventralized phenotype. (E) In stage 9 WT has strong nuclear Medea accumulation in the amnioserosa and dorsal-midline of cephalic region. (F) Stage 9 1Xdpp embryos often have a weak stripe of nuclear Medea accumulation in the cephalic region and variable but low levels in amnioserosa nuclei.